10,715
Participants
Start Date
June 19, 2021
Primary Completion Date
December 31, 2022
Study Completion Date
June 30, 2023
Dihydroartemisinin-piperaquine
DHA-PPQ will be given over the course of three consecutive days using 160mg/20mg or 320mg/40mg of dihydroartemisinin/piperaquine tablets. DHA-PPQ will be administered via age-based dosing. All three doses will be directly observed and given orally with water and without food.
Primaquine
Primaquine will be given once with the first dose of DHA-PPQ. Primaquine will be administered in an aqueous solution according to age-based dosing guidelines.
Tambacounda Health District, Tambacounda
Collaborators (1)
L'université de Thiès
OTHER
Programme National de Lutte contre le Paludisme (PNLP), Senegal
UNKNOWN
Population Services International
OTHER
Centers for Disease Control and Prevention
FED
US President's Malaria Initiative
UNKNOWN
University of California, San Francisco
OTHER